How Datt Capital tells of a temporary mispricing from a real deterioration in a business, and why it sold out of retail discretionary in August.
Rising rates strengthen Regis Healthcare's balance sheet, a genuine capital preservation feature few investors expect.
Firmus wants a $50bn valuation on a single AI bet. We explain why the discount sits in ASX small cap stocks building the infrastructure.
Datt Capital's Head of Research explains the drivers of lithium's rally, the supply outlook, and the main risks. Read more below.
Emanuel Datt on ASX reporting season dispersion, why Bravura Solutions outperformed and online retail names like Temple & Webster disappointed.
Large-cap tech momentum is slowing, and capital is rotating into ASX small caps and resources. Here is where the opportunity lies.
Ready to discuss your investment goals?